Benztrop™ Tablets (benzatropine mesilate)
Each Benztrop tablet contains 2 mg benzatropine mesilate, starch-pregelatinised maize, lactose, microcrystalline cellulose and magnesium stearate.
Indication:
For the treatment of all forms of parkinsonism and the treatment of extrapyramidal reactions (except tardive dyskinesia) due to neuroleptic drugs.
- Strength: 2 mg tablets
- Package: 60 tablet plastic bottle
- Status: PBS
- Phebra Code: TAB005
- Pack Size: 12 bottles
Resources: